Cargando…
From Proteomics to Personalized Medicine: The Importance of Isoflavone Dose and Estrogen Receptor Status in Breast Cancer Cells
Continuing efforts are directed towards finding alternative breast cancer chemotherapeutics, with improved safety and efficacy profiles. Soy isoflavones represent promising agents but, despite extensive research, limited information exists regarding their impact on the breast cancer cell proteome. T...
Autores principales: | Ilieș, Maria, Uifălean, Alina, Pașca, Sergiu, Dhople, Vishnu Mukund, Lalk, Michael, Iuga, Cristina Adela, Hammer, Elke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7766658/ https://www.ncbi.nlm.nih.gov/pubmed/33352803 http://dx.doi.org/10.3390/jpm10040292 |
Ejemplares similares
-
Plasma protein absolute quantification by nano-LC Q-TOF UDMS(E) for clinical biomarker verification
por: ILIES, MARIA, et al.
Publicado: (2017) -
Soy Isoflavones and Breast Cancer Cell Lines: Molecular Mechanisms and Future Perspectives
por: Uifălean, Alina, et al.
Publicado: (2015) -
Data on the impact of the blood sample collection methods on blood protein profiling studies
por: Ilies, Maria, et al.
Publicado: (2017) -
The Impact of Soy Isoflavones on MCF-7 and MDA-MB-231 Breast Cancer Cells Using a Global Metabolomic Approach
por: Uifălean, Alina, et al.
Publicado: (2016) -
Assessment of isoflavone aglycones variability in soy food supplements using a validated HPLC-UV method
por: UIFĂLEAN, ALINA, et al.
Publicado: (2015)